Marcum Wealth, LLC Laboratory Corp Of America Holdings Transaction History

Marcum Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$192.5 - $216.35 $1,540 - $1,730	-8 Reduced 0.79%	1,009 $205,000
Q1 2024 Apr 10, 2024	BUY	$209.01 - $232.56 $2,717 - $3,023	13 Added 1.29%	1,017 $222,000
Q4 2023 Jan 10, 2024	SELL	$197.69 - $227.29 $17,001 - $19,546	-86 Reduced 7.89%	1,004 $228,000
Q3 2023 Oct 10, 2023	BUY	$201.05 - $221.7 $13,872 - $15,297	69 Added 6.76%	1,090 $219,000
Q2 2023 Jul 13, 2023	BUY	$211.93 - $241.33 $10,384 - $11,825	49 Added 5.04%	1,021 $246,000
Q1 2023 Apr 19, 2023	BUY	$213.32 - $257.83 $207,347 - $250,610	972 New	972 $222,000
Q2 2022 Jul 14, 2022	SELL	$213.86 - $277.87 $168,307 - $218,683	-787 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$259.82 - $298.18 $204,478 - $234,667	787 New	787 $208,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Marcum Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Marcum Wealth, LLC with notifications on news.